StockNews.com started coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
The firm’s 50-day moving average price is $0.83 and its 200-day moving average price is $0.74. The firm has a market cap of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38. Onconova Therapeutics has a one year low of $0.55 and a one year high of $1.45.
Onconova Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Onconova Therapeutics
- Why Invest in High-Yield Dividend Stocks?
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Effectively Use the MarketBeat Ratings Screener
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- 5 Top Rated Dividend Stocks to Consider
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.